[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neurovascular Intervention Market – (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024

November 2018 | 82 pages | ID: G9655627EFBEN
Rockville Research

US$ 1,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
ARTS (Aspiration-Retriever Technique for Stroke) has emerged as a novel method for stroke treatment. The technique leads to more efficient reopening of large arterial occlusions by using large and flexible aspiration catheters as well as latest generations of stent retrievers; resulting in improved clinical outcomes.

The report “Global Neurovascular Intervention Market – (By Type-Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides an in-depth analysis of global neurovascular market overall as well as across market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, Carotid Artery Stenting (CAS) and Stent Retriever System. Market outlook for neurovascular intervention market overall as well as across various sub-segments has been provided for the period 2018-24. Regional analysis is done across major markets in North America, Europe and Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global neurovascular intervention market. The report has been segmented as following:-

Market Segments
  • Cerebral Thrombectomy Devices
  • Flow Diverter for Aneurysm
  • Carotid Artery Stenting (CAS)
  • Stent Retriever System
Geographical Coverage
  • North America - The US
  • Europe
  • Asia Pacific
Key Vendors
  • Johnson & Johnson DePuy Synthes
  • Stryker Corporation
  • Medtronic Plc.
  • Penumbra Inc.
  • Terumo Corporation
1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. NEUROVASCULAR MARKET

3.1 Introduction
  3.1.1 Background
  3.1.2 Neurovascular Devices
3.2 Market Analysis
  3.2.1 Market Sizing (Actual & Forecasted)
  3.2.2 Market Share by Region
  3.2.3 Market Share by Therapeutic Application
  3.2.4 Market Share by Technique

4. GLOBAL NEUROVASCULAR MARKET SEGMENTATION

4.1 Cerebral Thrombectomy Devices
  4.1.1 Overview
  4.1.2 Market Sizing (Actual & Forecasted)
  4.1.3 Market Share by Region
4.2 Flow Diverter for Aneurysm
  4.2.1 Overview
  4.2.2 Market Sizing (Actual & Forecasted)
  4.2.3 Market Share by Region
4.3 Carotid Artery Stenting (CAS) System
  4.3.1 Overview
  4.3.2 Market Sizing (Actual & Forecasted)
  4.3.3 Market Share by Region
4.4 Stent Retriever Market
  4.4.1 Overview
  4.4.2 Market Sizing (Actual & Forecasted)

5. REGIONAL ANALYSIS

5.1 North America (The US)
  5.1.1 Market Sizing (Actual & Forecasted)
  5.1.2 Market Share by Segment
  5.1.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
  5.1.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
  5.1.5 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
5.2 Europe
  5.2.1 Market Sizing (Actual & Forecasted)
  5.2.2 Market Share by Segment
  5.2.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
  5.2.4 Flow Diverter Devices Market Sizing (Actual & Forecasted)
5.3 Asia Pacific
  5.3.1 Market Sizing (Actual & Forecasted)
  5.3.2 Market Share by Segment
  5.3.3 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)

6. GLOBAL NEUROVASCULAR MARKET DYNAMICS

6.1 Industry Trends & Developments
  6.1.1 Mergers & Acquisitions
  6.1.2 Technological Advancement
  6.1.3 Advent of ARTS (Aspiration-Retriever Technique for Stroke)
6.2 Growth Drivers
  6.2.1 Rising Prevalence of Cerebrovascular disease
  6.2.2 Higher Incidences of Neurological Disorders
  6.2.3 Favorable Reimbursement Policies
  6.2.4 Expanding Healthcare Infrastructure
6.3 Challenges
  6.3.1 High Cost of Treatment
  6.3.2 Multiple Product Recalls
  6.3.3 Dearth of Skilled Neurosurgeons
  6.3.4 Social Stigma

7. COMPETITIVE LANDSCAPE

7.1 Global
7.2 Regional

8. COMPANY PROFILES

8.1 Johnson & Johnson DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic Plc.
8.4 Penumbra Inc.
8.5 Terumo Corporation


More Publications